|1.||Kizu, Tomoya: 1 article (04/2014)|
|2.||Sugiuchi, Tomone: 1 article (04/2014)|
|3.||Shimizu, Saki: 1 article (04/2014)|
|4.||Tatara, Ayaka: 1 article (04/2014)|
|5.||Andatsu, Saki: 1 article (04/2014)|
|6.||Miyoshi, Satoshi: 1 article (04/2014)|
|7.||Sato, Maho: 1 article (04/2014)|
|8.||Ohno, Yukihiro: 1 article (04/2014)|
|9.||Castorina, Alessandro: 1 article (03/2012)|
|10.||Leggio, Gian Marco: 1 article (03/2012)|
03/01/2012 - "Pretreatment with U-99194A, a D₃ receptor antagonist, reverted 7-OH-DPAT induced ocular hypotension in WT mice. "
06/01/2000 - "Pretreatment with raclopride, a D(2)/D(3) receptor antagonist; UH232, a D(3) receptor antagonist; or U-99194A, a D(3) receptor antagonist antagonized 7-OH-DPAT-induced ocular hypotension. "
06/01/2000 - "Suppression of 7-OH-DPAT-induced ocular hypotension by D(3) receptor antagonists (U-99194A and UH232) and sympathectomy, coupled with the immunohistochemical data, suggested that the primary site of D(3) receptor-mediated action of 7-OH-DPAT is located on postganglionic sympathetic nerve endings in the ciliary body of rabbit."
04/03/2014 - "In addition, U-99194A and AD-6048 per se significantly alleviated catalepsy induced by a high dose (0.5mg/kg) of haloperidol. "
04/03/2014 - "U-99194A (a selective D(3) antagonist) or AD-6048 (a preferential D(3) vs. D(2) antagonist) antagonized both the catalepsy enhancement and the locomotor inhibition with 7-OH-DPAT. "
10/01/1998 - "On the other hand, haloperidol, (+)-AJ 76, (+)-UH 232 and nafadotride all induced catalepsy in rats, whereas (+)-S 14297, U 99194 and GR 103,691 were inactive. "
01/01/1999 - "Thus, the inhibitory dose-response effects of a D2-preferring [sulpride], a D3-preferring [U 99194A] and combination of varying doses of these antagonists [sulpride + U 99194A] were evaluated on the ability of the cited agonists to produce vomiting. "
01/01/1999 - "However, U 99194A attenuated the potent antiemetic effect of sulpride on the apomorphine-induced emesis. "
01/01/1999 - "By itself, U 99194A failed to significantly alter the emesis produced by any of the cited agonists, however, it potentiated (3-8 times) the antiemetic effects of sulpride both in reducing the number of shrews vomiting as well as decreasing the mean vomiting frequency with the following ID50 order: PD 128, 907 < 7-(OH) DPAT < quinpirole. "
|4.||Dystonia (Limb Dystonia)
08/01/2010 - "In line with the unaltered D3 receptor binding, the preferential dopamine D3 versus D2 receptor antagonist U-99194 (5,6-dimethoxy-N,N-dipropyl-2,3-dihydro-1H-inden-2-amine hydrochloride) did not exert significant effects on the severity of dystonia in dt(sz) hamsters at doses of 10 to 40mg/kg which induced hyperlocomotion. "
|5.||Amnesia (Dissociative Amnesia)
|9.||1- (2- methoxy- phenyl)- 4- (4- (4- (6- imidazol(2,1- b) thiazolyl)- phenoxy)- butyl- 4- (14)C)- piperazine dimethane